# N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence

> **NCT00332605** · PHASE2 · COMPLETED · sponsor: **University of Chicago** · enrollment: 45 (actual)

## Conditions studied

- Methamphetamine Dependence

## Interventions

- **DRUG:** Naltrexone plus N-Acetyl Cysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00332605
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332605, "N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00332605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*